ACL Reconstruction
Conditions
Keywords
ACL, Anterior Cruciate ligament reconstruction, postoperative pain, corticosteroid taper, methylprednisolone taper, multimodal pain protocol
Brief summary
Patients who are being seen for ACL tears will be approached in the UAB Orthopedic Clinic. Included patients will be those aged 14-65 undergoing ACL Reconstruction. Excluded patients will be those with contraindications to corticosteroids. If the patient meets the criteria and agrees to participate, then the consent form will be signed, and the patient will be enrolled. Enrolled patients will be randomized to one of two groups. Patients in the treatment group will receive a 4 mg oral 6-day methylprednisolone taper in addition to standard post-operative pain control. Patients in the control group will receive standard post-operative pain control. All patients will receive the surgeon's standard ACL postoperative multimodal pain regimen. Endpoints will include narcotic consumption assessed daily and at one week post-op through a patient self-reported diary. The VAS pain score will be collected each day for the first week. Secondary endpoints will include range of motion and patient-reported outcomes, including IKDC, KOOS Jr, Tegner Activity Scale, ACL-RSI, and PROMIS Global collected at baseline, 2 weeks, 6 weeks and 3 months. All outcomes will be collected through PatientIQ.
Interventions
Participants will receive 4mg oral tablet of methylprednisolone taper for 6 days after surgery.
DRUGStandard Post-Operative Pain Control
All patients will receive the surgeon's standard ACL postoperative multimodal pain regimen.
COMBINATION_PRODUCTSurgeon's Standard ACL Postoperative Regimen
All patients will receive the surgeon's standard ACL postoperative multimodal pain regimen.
Sponsors
University of Alabama at Birmingham
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
14 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* aged 14-65 * undergoing ACL Reconstruction.
Exclusion criteria
* contraindications to corticosteroids
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Average Narcotic Consumption Post Surgery | Daily up to 6 days and 1 week post op | Paricipants will be assessed on the average amount of pain medication taken on a daily basis. |
| Percentage of overall Pain Post Operatively | Daily for 7 days post op | Participants will be evaluated using the Visual Analogue Scale (VAS) for pain is a self-reported tool, typically a 10-cm horizontal line, anchored by "no pain" (0 cm) and "worst pain" (10 cm). Patients mark their pain level, offering a simple, sensitive, and highly subjective assessment for acute, chronic, or disease-specific pain. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Range of Motion | baseline, 2 weeks, 6 weeks and 3 months | Participants will be measured on their range of motion after surgery using a goniometer. An instrument used to measure joint angles (range of motion) in rehabilitation and physical therapy, or to determine precise angular positions in engineering and physics. |
Countries
United States
Contacts
CONTACTAmit Momaya, MD
CONTACTCrystal Taylor
PRINCIPAL_INVESTIGATORAmit Momaya, MD
University of Alabama at Birmingham
Outcome results
None listed